It was further found that prevention of necroptosis activation either by IL-1β-siRNA or RIP1 antagonist could improve the neurodevelopment deficit caused by neonatal LPS injection, suggesting that necroptosis contributed to neuronal loss or injury following neonatal sepsis. The gene discussed is RIPK1; the disease is Sepsis.